RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
131 hedge funds and large institutions have $895M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 33 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
30% less capital invested
Capital invested by funds: $1.28B → $895M (-$390M)
Holders
131
Holding in Top 10
5
Calls
$3.33M
Puts
$3.86M
Top Buyers
| 1 | +$9.7M | |
| 2 | +$8.86M | |
| 3 | +$7.21M | |
| 4 |
CI
CPMG Inc
Dallas,
Texas
|
+$6.22M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$5.74M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$19.6M | |
| 3 | -$4.87M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.87M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$3.44M |